论文部分内容阅读
目的探讨降纤酶治疗脑血栓的临床疗效。方法选取2013年5月—2014年4月于吉安县中医院就诊的脑血栓患者78例,随机分为观察组和对照组,各39例。对照组给予低分子右旋糖酐治疗,观察组给予降纤酶治疗,比较两组患者的临床疗效、神经功能缺损量表(NIHSS)评分、起效时间及治疗时间。结果观察组患者总有效率高于对照组,NIHSS评分低于对照组,药物起效时间以及治疗时间均短于对照组,差异均有统计学意义(P<0.05)。结论降纤酶治疗脑血栓不仅可有效改善疗效,还能够缩短治疗时间、促进神经功能的恢复,提高预后质量。
Objective To investigate the clinical efficacy of defibrase in the treatment of cerebral thrombosis. Methods From May 2013 to April 2014, 78 patients with cerebral thrombosis who were treated in Ji’an Chinese Medicine Hospital were randomly divided into observation group and control group, 39 cases each. The control group was given low molecular dextran treatment. The observation group was given defibrase. The clinical efficacy, NIHSS score, onset time and treatment time were compared between the two groups. Results The total effective rate in the observation group was higher than that in the control group, NIHSS score was lower than that in the control group, the onset time and the treatment time were shorter than the control group, the difference was statistically significant (P <0.05). Conclusion Defibrase treatment of cerebral thrombosis not only can effectively improve the curative effect, but also shorten the treatment time, promote the recovery of nerve function and improve the quality of prognosis.